Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Aspero Medical
AddedFeb 16, 2024
UpdatedJun 18, 2026
Aspero Medical

Aspero Medical

Angel

Revolutionizing GI tract care with efficient, comprehensive endoscopic devices and innovative Pillar™ Technology.

HQ
Boulder, CO, US
Founded
2018
Overview
Compare
Fundraising
Employees
Website

Aspero Medical, founded with the mission to revolutionize gastrointestinal (GI) tract care, focuses on developing innovative endoscopic devices. Their core product, the Ancora-SB, utilizes proprietary Pillar™ Technology to enhance anchoring consistency within the GI tract, thereby reducing procedure time and improving the likelihood of complete procedures on the first attempt. Aspero Medical aims to address the challenges of balloon endoscopy, which is crucial for diagnosing and treating small bowel diseases.

Notable figures affiliated with Aspero Medical include its founding team, who bring extensive expertise in medical device innovation. The company has achieved significant milestones, including FDA clearance for the Ancora-SB device. This advancement underscores their impact on the medical field by offering a less invasive and more efficient alternative to traditional open surgery for small bowel disease. Aspero Medical's contributions are poised to improve patient outcomes and streamline GI tract procedures.

Aspero Medical - Similar Companies

Max Endoscopy logo

Max Endoscopy

maxendoscopy.com

EnVision Endoscopy logo

EnVision Endoscopy

Avantis Medical Systems logo

Avantis Medical Systems

avantismedical.com

Lazzaro Medical logo

Lazzaro Medical

lazzaromed.com

EvoEndo logo

EvoEndo

evoendo.com

Piccolo Medical logo

Piccolo Medical

piccolomedical.com

Syncro Medical Innovations logo

Syncro Medical Innovations

syncromedical.com

FastWave Medical logo

FastWave Medical

Early Bird Medical logo

Early Bird Medical

earlybirdmed.com

Anchor Balloon logo

Anchor Balloon

anchorballoon.com

Nectero Medical logo

Nectero Medical

necteromed.com

Oui-Medical. logo

Oui-Medical.

oui-medical.com

EmboMedics logo

EmboMedics

Advanced Medical Device Technologies logo

Advanced Medical Device Technologies

advancedmdt.com

East End Medical logo

East End Medical

Aspero Medical - Quick Facts

Who are Aspero Medical's competitors?

Companies similar to Aspero Medical include Max Endoscopy, EnVision Endoscopy, Avantis Medical Systems and Lazzaro Medical.

When was Aspero Medical founded?

Aspero Medical was founded in 2018.

Where is Aspero Medical's headquarters located?

Aspero Medical's headquarters is located in Boulder, CO, US.

How much has Aspero Medical raised to-date?

As of Jan 1, 2022, Aspero Medical has raised a total of $1.8M (USD).

How many employees does Aspero Medical have?

Aspero Medical has 8 employees as of Feb 5, 2024.

Aspero Medical - Classification

Industry
  • Hardware
Ownership
  • Venture Capital
Technology
  • Robotics
Geographic Exposure
  • Global
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Medical Devices
Tags
  • Healthtech
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
SIC
  • 5000Wholesale Trade-durable Goods
  • 5040Professional And Commercial Equipment And Supplies
  • 5047Medical, Dental, And Hospital Equipment And Supplies
Show 7 more industry codes
NAICS
  • 330000Manufacturing
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 3900Miscellaneous Manufacturing Industries
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified